0001209191-20-001230.txt : 20200103 0001209191-20-001230.hdr.sgml : 20200103 20200103172122 ACCESSION NUMBER: 0001209191-20-001230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MacLean Michael F CENTRAL INDEX KEY: 0001383731 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 20506821 MAIL ADDRESS: STREET 1: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-02 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001383731 MacLean Michael F C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 16.99 2020-01-02 4 A 0 57000 0.00 A 2030-01-01 Common Stock 57000 57000 D The shares vest as follows: 1/4th of the shares vest one year after January 2, 2020; 1/48th of the shares vest monthly thereafter over the next three years. /s/ Joshua F. Patterson, Attorney-in-Fact 2020-01-03